
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Leukemia - Acute
AML not otherwise categorized
Myeloid sarcoma
Reviewer: Daniela Mihova, M.D. (see Reviewers page)
Revised: 20 March 2013, last major update September 2012
Copyright: (c) 2001-2013, PathologyOutlines.com, Inc.
General
=========================================================================
● Extramedullary tumor mass of neoplastic immature myeloid (granulocytic or monocytic) cells
● Also called extramedullary myeloid tumor, granulocytic sarcoma, chloroma
● See also descriptions in various chapters
● Often misdiagnosed, particularly without immunostains
● Present in 2-8% of AML patients; prognosis is that of underlying leukemia
● Equivalent to blast transformation in setting of myelodysplastic syndrome or myeloproliferative disease (Korean J Lab Med 2006;26:143)
● Usually associated with AML M4 or M5 (M4e or M5a in children), CML, chronic idiopathic myelofibrosis, hypereosinophilic syndrome or polycythemia vera
● Rarely no leukemia / myelodysplasia is identified in blood or bone marrow (J Neurosurg 2006;105:916)
● Common sites: lymph nodes, subperiosteal bone, skin, orbit, spinal canal and mediastinum
Case reports
=========================================================================
● 27 year old woman with punched-out, lytic, intramedullary lesion in fibula (Case of the Week #130)
Treatment
=========================================================================
● Aggressive treatment recommended (Leukemia 2007;21:340, Cancer 2002;94:1739)
● Usually evolves to AML or has additional tumor masses at other sites
Gross images
=========================================================================
Micro description
=========================================================================
● Blastic type: myeloblasts with mild / moderate rim of basophilic cytoplasm, fine nuclear chromatin, 2-4 nucleoli
● Immature type: myeloblasts, promyelocytes, eosinophilic myelocytes
● Differentiated type: promyelocytes, eosinophilic myelocytes and more mature forms; rarely crystalline inclusions similar to Charcot-Leyden crystals (Arch Pathol Lab Med 2002;126:85)
Micro images
=========================================================================
Differentiated (left) versus blastic Various images
types (center and right)-site unknown
Lymph node:

Cells have fine chromatin resembling Large blast cells resemble large cell lymphoma,
lymphoblastic lymphoma also some eosinophilic myelocytes

Tumor cells have irregularly Resembles lymphoblastic lymphoma,
folded and convoluted nuclei but has cytoplasmic granules and distinct nuclei
Many tumor cells have azurophilic Tumor cells mix with residual normal lymphocytes
granules
Immature cells with moderate to abundant cytoplasm,
round / oval nuclei, distinct and prominent nucleoli and immature eosinophils
Lymph node has prominent eosinophilic myelocytes and blasts
Case of the week #130 (bone):

CD45 / LCA
CD45RO CD3 CD34 CD20
Other:
Anorectal ulcer
Appendix
Breast Has blasts with numerous azurophilic granules
and promyelocytes, classified as AML with maturation
Bladder Skin-eosinophilic myelocytes and blasts
Small intestine
Orbital mass with t(8;21) has blasts with immature eosinophils
Soft tissue of paracervical Spinal dura-some tumor cells
spine (H&E and CD99) have cytoplasmic granules
Testes
Stains:
Myeloperoxidase: Lymph node Mediastinum Breast (left), CD43 (right)
Skin: various stains
CD68: Spine Uterus
Chloroacetate esterase - lymph node Lysozyme - orbit
Cytology description
=========================================================================
● Usually background lymphoglandular bodies
● Auer rods and eosinophilic myelocytes are rare
● Resembles large cell lymphoma (Cancer 2000;90:364)
Cytology images
=========================================================================

Breast: has blasts with numerous azurophilic granules and promyelocytes, classified as AML with maturation
Positive stains
=========================================================================
● Almost all tumors: lysozyme and CD43
● Myeloid tumors: myeloperoxidase and CD117
● Myeloblasts: CD13, CD33 (Arch Pathol Lab Med 2001;125:1448)
● Monocytic tumors: CD68 and variable CD163 (Am J Clin Pathol 2004;122:794)
● Monoblasts: CD11c (Diagn Pathol 2007;2:42), CD14, CD56 (Am J Clin Pathol 2000;114:807), CD99 (55%, Mod Pathol 2000;13:452), HLA-DR and chloroacetate esterase (Ann Saudi Med 2001;21:287)
● Other: CD4, CD34 and TdT
Negative stains
=========================================================================
● CD3, CD20, CD34 and CD79a
Molecular description
=========================================================================
● Most common are monosomy 7 (11%), trisomy 8 (10%) and MLL rearrangements (9%)
● Also inv(16), trisomy 4, monosomy 16, 16q-, 5q-, 20q-, trisomy 11, t(8;21)(q22;q22) in pediatric cases and NPM1 mutations (16%)
Differential diagnosis
=========================================================================
● Burkitt lymphoma
● Poorly differentiated lymphoma
● Small round cell tumors
Myeloid sarcoma of female genital tract
=========================================================================
● Rare, but may be initial clinical presentation
● Usually ovary, also vagina and cervix (Am J Surg Pathol 1997;21:1156, Am J Clin Pathol 2006;125:783)
● Mean age 40 years, range 13-76 years
● Enzyme cytochemistry: chloroacetate esterase, lysozyme, myeloperoxidase, CD43, CD68, CD117
Micro description
=========================================================================
● Usually diffuse growth pattern, also cords and pseudoacinar spaces; sclerosis common
Micro images
=========================================================================
Left to right: Pelvic mass (various images), uterus (various images)
Differential diagnosis
=========================================================================
● Carcinoma
● Granulosa cell tumor
● Lymphoma
End of Leukemia - Acute > AML not otherwise categorized > Myeloid sarcoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).